GGrantIndex
← Leaderboards

Jorge Santana

University Of Puerto Rico Med Sciences

$10,874,849
Attributed
$10,874,849
Total exposure
13
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.7M · FY200506
$2M$1.5M$1M$500K$0
'05
'06

Funding mix

By agency

NIH$10,874,849 · 13

By mechanism

U01$10,664,241 · 1
P20$210,608 · 12

Top collaborators

No co-investigators on record.

Most similar at University Of Puerto Rico Med Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trial Phase I

Research focus

Clinical Trial Phase IStatistics /BiometryPneumocystis PneumoniaAids Related Neoplasm /CancerAids /Hiv NeuropathyDrug Adverse EffectPathologic ProcessClinical ResearchCooperative StudyCytomegalovirusDrug InteractionsExperimental DesignsGender DifferenceGlucose MetabolismHepatitis B Virus GroupHepatitis C VirusHistoplasmaHiv InfectionsHuman Immunodeficiency Virus 1Human SubjectHuman Therapy EvaluationHydroxyureaImmunoregulationImmunotherapy

Grant awards (19)

ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,451,816
U01 · FY2006 · AI · contact PI
A5178: "PEG-IFN PLUS RBV FOR HCV CO-INFECTION"$20,236
P20 · FY2006 · RR · contact PI
A5157 "PILOT STUDY OF ACETYL-L-CARNITINE IN DSPN"$20,226
P20 · FY2006 · RR · contact PI
TDM ON VIRAL LOAD RESPONSE TO PROTEASE INHIBITOR CONTAINING SALVAGE THERAPY$20,221
P20 · FY2006 · RR · contact PI
A5223-SEX DIFFERENCES IN LOPINAVIR/RITONAVIR PHARMACOKINETICS$20,221
P20 · FY2006 · RR · contact PI
ANTIRETROVIRAL EFFECT OF IMMUNIZATION WITH THE MRK AD5 HIV-1 GAG VACCINE$20,221
P20 · FY2006 · RR · contact PI
PILOT STUDY - A5173$20,221
P20 · FY2006 · RR · contact PI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,569,766
U01 · FY2005 · AI
ACTG-736$14,877
P20 · FY2005 · RR
A5157 "PILOT STUDY OF ACETYL-L-CARNITINE IN DSPN"$14,877
P20 · FY2005 · RR
ATAZANAVIR/ RITONAVIR MAINTENANCE THERAPY$14,877
P20 · FY2005 · RR
ANTIRETROVIRAL EFFECT OF IMMUNIZATION WITH THE MRK AD5 HIV-1 GAG VACCINE$14,877
P20 · FY2005 · RR
TDM ON VIRAL LOAD RESPONSE TO PROTEASE INHIBITOR CONTAINING SALVAGE THERAPY$14,877
P20 · FY2005 · RR
A5126$14,877
P20 · FY2005 · RR
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,562,076
U01 · FY2004 · AI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,598,938
U01 · FY2003 · AI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,485,785
U01 · FY2002 · AI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,510,774
U01 · FY2001 · AI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,485,086
U01 · FY2000 · AI